Skip to content

Plain-English explainer

Wegovy Constipation & Diarrhea: Managing GI Side Effects

By Updated

We keep this plain-English — no jargon, every claim sourced.

On this page

Featured partner

CoreAge Rx

$99/mo flat

Doctor-reviewed semaglutide with one flat price and built-in human support.

Check availability
Category
Telehealth · semaglutide
Pricing
Flat monthly price
Support
Nurse + dietitian consults
Labs
No labs required

Advertising disclosure · we may earn a commission at no extra cost to you.

Partner

HealthRX

Weekly compounded semaglutide at one plan price, and the longer you prepay, the lower the month.

$165/mo (first month $149)

Check HealthRX availability

Constipation, diarrhea and nausea are reported during Wegovy treatment. Many trial events were mild or moderate, but a listed side effect is not a reason to dismiss persistent, severe or unusual symptoms. The useful questions are what changed, how long it has lasted and whether you can eat and drink normally.

Wegovy acts on appetite pathways and can delay gastric emptying, but the evidence does not establish one direct mechanism for every bowel symptom48. A cited 20-week trial of semaglutide 2.4 mg found no evidence of delayed gastric emptying at that time using indirect paracetamol absorption; it should not be treated as proof of a universal slowdown5. Burping and reflux are distinct reported symptoms with their own evidence limits.

How common are GI side effects, really?

In the label’s pooled adult 2.4 mg weekly injection weight-management trials, nausea was reported in 44% versus 16% with placebo, diarrhea in 30% versus 16%, and constipation in 24% versus 11%. Vomiting and abdominal pain were also common8. These figures are not exact rates for every Wegovy dose, tablet formulation or individual. Those are real numbers, but two points temper them: most cases were mild to moderate, and they were most frequent during dose escalation — the period when the dose is being stepped up — then generally eased over time8.

The phase-3 trials tell the same story. In STEP 1 (semaglutide 2.4 mg in adults with overweight or obesity without diabetes), GI events were the most common adverse effects, were typically transient, and were the main reason a minority of participants discontinued1. In STEP 2 (adults with type 2 diabetes), the pattern held — gastrointestinal disorders led the side-effect profile and were generally mild to moderate2. Timing alone cannot determine whether a symptom is safe to manage at home.

Why the dose goes up slowly (and why that matters here)

The labeled injection escalation is intended to reduce gastrointestinal adverse reactions. If a dose is not tolerated during escalation, the label allows the prescriber to consider delaying the next increase8. Different trials used planned escalation, but that does not establish a single best symptom remedy for everyone3. If a given step is rough, prescribers can hold you at the current dose longer before going up — a standard, legitimate adjustment, not a failure. For how the full ladder works, see our semaglutide dosing and side effects guide.

Managing constipation

Constipation can occur during treatment, but other medicines, eating patterns and medical conditions can also contribute. Options to discuss depend on severity and your history:

  • Check your fluid plan. Avoid fluid depletion, but follow existing heart/kidney fluid or mineral restrictions. Seek advice if you cannot keep drinks down.
  • Fiber, gradually. More vegetables, fruit, whole grains, and legumes — added slowly so you do not trade constipation for bloating. A bulk-forming or osmotic over-the-counter laxative can help, but clear it with your prescriber or pharmacist first.
  • Move. Regular physical activity supports normal bowel function.

These align with the practical management guidance for GLP-1 GI effects in the clinical literature6. The bigger picture of how to eat on the drug — protein first, fiber ramped up gently, steady hydration, small slow meals — is laid out in what to eat on Wegovy. If constipation is severe, persistent, or paired with significant abdominal pain or vomiting, seek assessment. If you are considering a supplement, probiotics with semaglutide explains why benefits are strain- and condition-specific rather than a routine side-effect fix.

Managing diarrhea

Diarrhea is the flip side and, for some people, shows up instead of (or alongside) constipation. Helpful approaches:

  • Hydrate to replace losses — water, and where appropriate fluids with electrolytes — since diarrhea can dehydrate you.
  • Ease off the usual triggers — very greasy, fried, or heavily spiced meals, and for some people large amounts of caffeine or sugar alcohols.
  • Smaller, plainer meals during a flare are gentler than large rich ones.

Diarrhea, like the other GI effects, is usually mild and tends to settle as you adjust68. Watch for dehydration (dizziness, very dark urine, marked thirst) — and note that volume depletion is an important setting for reported kidney injury, which is why staying hydrated is more than comfort advice8. We give the dedicated hydration-and-electrolyte plan and the kidney red flags in semaglutide and dehydration, and unpack the broader organ-specific risk, alongside the gallbladder signal, in semaglutide and your gallbladder/kidneys.

If you already have Crohn’s disease or ulcerative colitis, do not assume new diarrhea is simply a medication adjustment. Our semaglutide and inflammatory bowel disease guide covers that separate condition and the need for coordinated assessment.

Managing nausea (the most common one)

Nausea tops the list, and the practical playbook is well established: eat smaller portions, stop at the first sign of fullness, eat slowly, and favor blander, lower-fat foods while easing up on very rich or greasy meals6. These are comfort measures to discuss, not proof that one food or gastric-emptying mechanism explains your symptoms. Gastrointestinal reactions were often reported during dose escalation, but no single resolution timeline fits everyone8.

What is normal vs. when to call your prescriber

Choose the next step by severity

Symptoms may improve, but persistence or severity matters more than whether they began during escalation. Seek prompt medical advice for severe or persistent abdominal pain, especially radiating to the back with or without vomiting, dehydration or inability to keep fluids down8. Do not wait for a set number of weeks when these occur.

A note on compounded and gray-market semaglutide

Every figure above comes from trials and the FDA label for FDA-approved, standardized Wegovy8. Compounded semaglutide from some telehealth and med-spa sources is a different situation: dose accuracy and formulation can vary, titration may be looser, and the tidy "side effects ease during a slow ramp" expectation does not automatically transfer. Products from unregulated online sellers are riskier still. If you are weighing where to get semaglutide, our best semaglutide providers guide compares options on price and oversight, and the pillar Semaglutide: How It Works, Results & Side Effects lays out the full evidence picture.

The honest bottom line

Constipation, diarrhea, and nausea are Wegovy's most common side effects, they cluster around dose increases, and for most people they are mild to moderate and temporary18. Follow the prescribed escalation and discuss symptoms before increasing. Meal changes, appropriate fluids and other measures may help, but they do not guarantee relief or replace assessment68. Keep an eye out for the genuine red flags, loop in your prescriber rather than self-adjusting the dose, and remember this is general education, not medical advice for your specific situation. For what to expect on the scale while you ride out the early weeks, see when does Wegovy start working?. And because alcohol is itself a gut irritant that can amplify nausea on a drug that already slows the stomach, it is worth reading whether you can drink alcohol on Wegovy or Ozempic.

A few more quick ones

What are common Wegovy gastrointestinal side effects?

In adult 2.4 mg injection trials, nausea occurred in 44%, diarrhea in 30% and constipation in 24%; placebo rates were 16%, 16% and 11%. Vomiting and abdominal pain were also common. Other doses and formulations have different evidence.

Can Wegovy cause both constipation and diarrhea?

Both are reported reactions, but a single gastric-emptying explanation does not establish the cause of every episode. Other medicines, infection or an existing bowel condition may need assessment.

How long do bowel side effects last?

Many trial events were mild or moderate and occurred during dose escalation, but there is no universal time to resolution. Persistent, worsening or disruptive symptoms deserve review; severe symptoms should not wait for a timeline.

Should I add a probiotic?

Not automatically. Probiotic benefits depend on the strain, condition and patient. Evidence for another type of diarrhea does not prove prevention or treatment of semaglutide bowel symptoms.

When should I call about Wegovy side effects?

Seek prompt assessment for severe or persistent abdominal pain, signs of dehydration or inability to keep fluids down. Contact the prescriber for symptoms that persist, worsen or interfere with eating, drinking or daily life.

Where this comes from

Sources include clinical studies, official labeling, and company pricing pages. Company-source links below lead to our provider pricing and source checks.

  1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).. N Engl J Med. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Davies M, Færch L, Jeppesen OK, et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.. Lancet. https://pubmed.ncbi.nlm.nih.gov/33667417/
  3. Sorli C, Harashima SI, Tsoukas GM, et al. (2017). Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.. Lancet Diabetes Endocrinol. https://pubmed.ncbi.nlm.nih.gov/28110911/
  4. Drucker DJ (2022). GLP-1 physiology informs the pharmacotherapy of obesity.. Mol Metab. https://pubmed.ncbi.nlm.nih.gov/34626851/
  5. Friedrichsen M, Breitschaft A, Tadayon S, et al. (2021). The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.. Diabetes Obes Metab. https://pubmed.ncbi.nlm.nih.gov/33269530/
  6. Wharton S, Davies M, Dicker D, et al. (2022). Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice.. Postgrad Med. https://pubmed.ncbi.nlm.nih.gov/34775881/
  7. Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.. JAMA. https://pubmed.ncbi.nlm.nih.gov/33755728/
  8. Novo Nordisk Pharmaceutical Industries, LP (2026). WEGOVY (semaglutide) injection — FDA Prescribing Information (DailyMed).. DailyMed (NLM), FDA label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.